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In primate cells, assembly of a single HIV-1 capsid involves
multimerization of thousands of Gag polypeptides, typi-
cally at the plasma membrane. Although studies support
a model in which HIV-1 assembly proceeds through com-
plexes containing Gag and the cellular adenosine triphos-
phatase ABCE1 (also termed HP68 or ribonuclease L
inhibitor), whether these complexes constitute true
assembly intermediates remains controversial. Here we
demonstrate by pulse labeling in primate cells that a pop-
ulation of Gag associates with endogenous ABCE1 within
minutes of translation. In the next  2 h, Gag–ABCE1
complexes increase in size to approximately that of imma-
ture capsids. Dissociation of ABCE1 from Gag correlates
closely with Gag processing during virion maturation and
occurs much less efficiently when the HIV-1 protease is
inactivated. Finally, quantitative double-label immunogold
electron microscopy reveals that ABCE1 is recruited to
sites of assembling wild-type Gag at the plasma mem-
brane but not to sites of an assembly-defective Gag
mutant at the plasma membrane. Together these findings
demonstrate that a population of Gag present at plasma
membrane sites of assembly associates with ABCE1
throughout capsid formation until the onset of virus
maturation, which is then followed by virus release.
Moreover, thedatasuggestalinkagebetweenGag–ABCE1
dissociation and subsequent events of virion production.
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HIV-1 Gag polypeptides are synthesized and myristoylated
in the cytoplasm of infected cells, and then subsequently
traffic to the cytoplasmic face of the plasma membrane or
other membranes for capsid formation. Assembly of
a single capsid involves multimerization of  5000 Gag
polypeptides (1), as well as encapsidation of two copies of
HIV-1 genomic RNA and other viral proteins. Immature
capsid assembly is followed by capsid maturation, which is
mediated by the HIV-1 protease, as well as by budding and
virus release. Although Gag has self-assembling properties
(2–4), the complexity of assembly in cells raises the
possibility that cellular proteins may play critical roles
duringGagassembly.Anumberofstudiessupportamodel
of HIV-1 capsid assembly in which Gag assembles into
capsids by progressing through a post-translational path-
way of assembly intermediates, requiring involvement of
the cellular adenosine triphosphatase (ATPase) ABCE1
(5–9). Initial evidence for this model was acquired through
studies in a cell-free system that reconstitutes immature
HIV-1 capsid formation in a eukaryotic cell extract. Pulse-
chase studies in this system initially revealed the existence
ofassemblyintermediatesbydemonstratingthatHIV-1Gag
progresses sequentially through a series of high-molecular-
weight complexes during capsid assembly. Cell-free studies
also demonstrated that energy is required post-translation-
ally at a specific point in this pathway for completion of
assembly (8). The observation that ATP is utilized during
assembly led to the identification of an ATP-binding cellular
protein, ABCE1 [previously termed HP68 or ribonuclease
(RNAse) L inhibitor], which associates with assembling Gag
polypeptides in high-molecular-weight assembly intermedi-
ates. Studies using depletion–reconstitution in the cell-free
system demonstrated that ABCE1 is critical for post-trans-
lationaleventsofcapsidassemblyandhavebeenconfirmed
using a dominant-negative mutant in primate cells (9).
Although HIV-1 capsid assembly intermediates were first
identified in a cell-free HIV-1 capsid assembly system,
subsequent studies of primate cells expressing HIV-1 or
other primate lentiviral Gag proteins identified ABCE1-
containing complexes that correspond to assembly inter-
mediates in their size, composition and energy sensitivity
(5,9). However, numerous questions remain unanswered
about these intracellular complexes. Here we use pulse-
chase radiolabeling in primate cells to demonstrate that
Gag is associated with ABCE1, from Gag synthesis until
completion of Gag assembly and the onset of Gag poly-
peptide processing during capsid maturation. A proviral
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www.traffic.dk 195mutant containing an inactivated protease results in
delayed release of virus, as expected from studies of others
(10), but also prolongs the association of Gag with ABCE1.
These data raise the possibility that dissociation of ABCE1
from Gag at the completion of assembly is linked to sub-
sequenteventsofproteasematuration.Moreover,whileGag
is associated with ABCE1, it increases in size from relatively
smallcomplexestolargecomplexesthatapproachthesizeof
completed immature capsids. Finally, we demonstrate via
quantitative immunogold electron microscopy (EM) double
labeling that wild-type Gag recruits ABCE1 to assembling
structures at the plasma membrane, while an assembly-
defective Gag mutant that targets to the plasma membrane
does not recruit this cellular protein. Notably, using this
ultrastructural approach, we demonstrate that electron-
dense structures at the plasma membrane that have long
beenrecognized as assembling virions appear to constitute
assembly intermediates containing Gag and ABCE1.
Results
Kinetic analysis reveals that disappearance of
intracellular Gag–ABCE1 complexes correlates with
appearance of p24Gag in the medium
Previously, using a cell-free HIV-1 capsid assembly sys-
tem, we demonstrated that ABCE1 associates only tran-
siently with p55Gag, releasing from p55Gag upon
completion of capsid assembly (9). Consistent with this,
ABCE1 is not found in virions released from cells but is
associated with intracellular p55Gag at steady state (5). If
complexes containing HIV-1 p55Gag and ABCE1 in primate
cells represent transient post-translational assembly inter-
mediates as predicted by results obtained in the cell-free
capsid assembly system, then a kinetic analysis in cells
should reveal that these complexes appear shortly after
completion of p55Gag synthesis and disappear as assem-
bly is completed and virions are released. To analyze the
kinetics of p55Gag progression through these ABCE1-
containing complexes, we pulse-labeled cells and used
immunoprecipitation to follow these radiolabeled com-
plexes over time. Before examining complexes containing
p55Gag and ABCE1, we first determined the time-course
of p55Gag synthesis and release into the medium by
immunoprecipitating cell lysates and medium with anti-
body to Gag (aGag) after denaturation. COS-1 cells ex-
pressing an HIV-1 provirus with the viral env gene deleted
(HIV) were pulse labeled for 6 min with
35S-methionine/
cysteine and chased for different periods of time with
unlabeled medium. Synthesis of radiolabeled p55Gag
peaked at 30 min into the chase and then decreased until
p55Gag was no longer visible at >24 h into the chase
period (Figure 1A, Cells). Over time, p55Gag was cleaved
into 41-, 25- and 24-kD polypeptides that were immuno-
precipitated by aGag (directed against the p24 capsid
domain of Gag), consistent with processing of the
p55Gag precursor protein by the HIV-1 protease during
the virus maturation step that follows assembly. Gag
began to appear in the medium in the form of p24Gag at
75 min into the chase period and continued to accumulate
in the medium for over 24 h (Figure 1A, Medium).
Next, we examined the formation of complexes containing
p55Gag and ABCE1 in radiolabeled cells. Previously, we
used immunoprecipitation with affinity-purified antibody to
ABCE1 (aABCE1) followed by Western blotting with aGag
to show that p55Gag associates with endogenous un-
labeled ABCE1 in primate cells at steady state (5,9). To
determine whether newly synthesized p55Gag in radio-
labeled HIV-expressing cells associates with endogenous
ABCE1, we performed immunoprecipitations under native
conditions (which preserve protein–protein interactions)
on cell lysates from radiolabeled COS-1 cells transfected
with HIV or mock plasmid. We observed immunoprecipi-
tation of a prominent 68-kD radiolabeled protein in both
HIV-expressing and mock cells that aligned with an ABCE1
marker (Figure 1B, compare lanes 3 and 4 to 2). In addition,
a prominent 55-kD radiolabeled band that aligned with a
Gag marker (Figure 1B, compare lanes 3 to 1) was co-
immunoprecipitated by aABCE1 from HIV-expressing
cells, but not from mock-transfected cells (Figure 1B,
compare lanes 3 and 4). Immunoprecipitations using non-
immune serum revealed that immunoprecipitated bands
were specific to aABCE1 (Figure 1B, lanes 5 and 6). It
should be noted that a number of other radiolabeled bands
were also coimmunoprecipitated by aABCE1 under native
conditions in both mock and HIV-expressing cells (Figure
1B, lanes 3 and 4). The pattern of radiolabeled bands
coimmunoprecipitating with aABCE1 appeared identical in
immunoprecipitations from HIV and mock-transfected
samples, with the exception of the 55-kD band that was
only immunoprecipitated from cells expressing HIV.
ABCE1, which is critical for ribosome biogenesis, nuclear
export of ribosomes and translation initiation (11–14), binds
to translation initiation factors, such as eIF2 (11,12), eIF3
(11,12,14) and eIF5 (11,12), as well as a variety of ribo-
somal proteins (13). Thus, it is likely that the other proteins
coimmunoprecipitated by aABCE1 represent these and
other factors, most likely in multiple separate complexes.
To ensure that the 55-kD protein represents HIV-1 Gag and
not another protein of similar size, we performed serial
immunoprecipitations on eluates from aABCE1 immuno-
precipitations. COS-1 cells expressing HIV were subjected
to immunoprecipitation with aABCE1 under native con-
ditions, followed by elution in 1% SDS (Figure 1C, lanes
1 and 5). The denatured eluate was diluted, divided into
equivalent aliquots and subjected to immunoprecipitation
using antibodies to ABCE1, Gag, actin or nonimmune
serum. This second round of immunoprecipitations con-
firmed that radiolabeled ABCE1 and p55Gag were present
in the eluate of the original aABCE1 immunoprecipitation
(Figure 1C, lanes 2 and 3, respectively), while actin was
absent (Figure 1C, lane 6), and the nonimmune control
revealed no bands (Figure 1C, lane 4). Gag was also
immunoprecipitated from the eluate of the aABCE1
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against Gag (J.E. Dooher and J.R. Lingappa, unpublished
data). These results confirm that newly synthesized full-
length Gag associates with endogenous ABCE1 in radio-
labeled cells, as expected.
Next, we examined the time-course of Gag association
with ABCE1 by radiolabeling COS-1 cells expressing HIV
for 15 min and performing aABCE1 coimmunoprecipita-
tions under native conditions at different chase times.
p55Gag was clearly associated with ABCE1 at the 10 and
15 min chase times and was associated to a lesser extent
at 22–65 min (Figure 2A, black dot). Minimal association of
Gag with ABCE1 was observed from 65 min to 5 h, and
after that, no significant association was detected. Similar
results were obtained when lysates were harvested in
Figure 1: Sequential immunoprecipita-
tion validates the finding that radio-
labeled p55Gag associates with ABCE1.
A) COS-1 cells expressing HIV-1 were
pulsed for 6 min with
35S-methionine/cys-
teine and chased with unlabeled medium
for 15 min to 72 h as indicated. Cell lysates
(A, top panel) and medium (A, bottom
panel) were harvested, denatured, and
subjected to immunoprecipitation with
aGag. Marker lane (M Gag) indicates the
position of full-length Gag and Gag cleav-
age products. B) COS-1 cells transfected
with HIV (lanes 3 and 5) or mock plasmid
(lanes 4 and 6) were pulsed for 45 min with
35S-methionine/cysteine and chased with
unlabeled medium for 15 min. Lysates
were subjected to immunoprecipitation
under native conditions with aABCE1
(IP: ABCE) or nonimmune serum (IP:
NIS). Lanes 1 and 2 are marker lanes (M)
that indicate the position of Gag and
ABCE1. Dot indicates position of coimmu-
noprecipitated p55Gag in lane 3. C) COS-1
cells expressing HIV were pulsed for 1 h
with
35S-methionine/cysteine and chased
with unlabeled medium for 15 min. Ly-
sates were subjected to native immuno-
precipitation with aABCE1 (ABCE, lanes 1
and 5), and eluates from these initial im-
munoprecipitations were programmed into
a second round of immunoprecipitations,
indicated with black bar, using aABCE1
(lane 2), aGag (lane 3), nonimmune anti-
body (lane 4) or actin antibody (lane 6).
Marker indicates position of actin (M actin,
lane 7). Asterisk indicates position in lane 2
of a frequently seen  45-kD band that
cross-reacts with aABCE1. Molecular
weight markers or positions of ABCE1 or
Gag are indicated beside all panels. All
lanes in a given panel are from the same
autoradiograph, with dividing lines indicat-
ing where lanes from other regions of the
same autoradiograph are spliced. All data
are representative of four independent
experiments.
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RNAse A (Figure S1), indicating that this association was
not dependent on intact ribosomes or polysomes. Thus,
a population of newly synthesized p55Gag appeared to be
associated with ABCE1 in the first  5 h of the chase
period. Next, we compared the kinetics of complexes
containing p55Gag and ABCE1 with the appearance of
the p24Gag cleavage product in the medium (representing
released, mature virus). Medium collected at different
chase times was denatured and subjected to immuno-
precipitation with aGag. Autoradiographs demonstrated
that radiolabeled p24Gag began appearing in the medium
at 35–65 min (Figure 2B).
To compare the kinetics of the Gag–ABCE1 complex to the
kineticsof Gag release, the amountof radiolabeled p55Gag
associated with ABCE1 in cell lysates and the amount of
radiolabeled p24Gag present in the medium were quanti-
fied and graphed. Radiolabeled Gag appeared to be
released into the medium in two phases. In the first phase,
which lasts for   5 h after pulse labeling, radiolabeled
p24Gag was released at a rapid rate, while subsequent
release occurred at a slower rate (Figure 2C). These
graphs also revealed that the disappearance of intracellular
Gag–ABCE1 complexes during the first 5 h into the chase
period was inversely correlated with the appearance of
p24Gag in the medium. The loss of Gag–ABCE1 com-
plexes at this stage is consistent with dissociation of
ABCE1 from Gag upon completion of capsid assembly,
which we had documented previously in a cell-free system
for HIV-1 capsid assembly [figure S1 in Zimmerman et al.
(9)]. In the cell-free system, total radiolabeled Gag and
radiolabeled Gag–ABCE1 complexes could be accurately
quantified, thereby ruling out degradation and confirming
ABCE1 dissociation as the reason for the loss of Gag–
ABCE1 complexes at the completion of assembly. To date,
we have observed an excellent correspondence between
results obtained in the cell-free system for HIV-1 capsid
assembly and results obtained in cells (5,7–9), but it
remains possible that the loss of intracellular Gag–ABCE1
complexes is due to their degradation rather than due to
dissociation of ABCE1 from Gag.
Notably, a delay was seen when comparing the loss of
intracellular Gag–ABCE1 complexes to the appearance of
virus in the medium (Fig. 2c). For example, 50% of Gag–
ABCE1 complexes were lost by 2 h into the chase, while
 10 h elapse before 50% of virus was released into the
medium. This apparent lag between the likely dissociation
of ABCE1 from p55Gag and appearance of p24Gag in the
medium could be explained by the time it takes for pro-
teolytic processing and/or budding, which follow comple-
tionofimmaturecapsidformation.Whenwecomparedthe
disappearance of Gag–ABCE1 complexes to the appear-
ance of intracellular p24Gag and p25Gag in these experi-
ments (Figure 2D), we observed very close timing without
adelay.Thus,lossoftheGag–ABCE1associationappeared
to correlate very closely in time with the onset of intracel-
lular processing of p55Gag, which was followed, after
a delay, by virus release. Together, these data indicate that
a population of p55Gag is associated with ABCE1 from the
time of synthesis until the onset of p55Gag processing.
An assembly-incompetent Gag mutant fails to form
ABCE1 complexes, whereas an assembly-competent
HIV mutant displays prolonged Gag association
with ABCE1
Previously, we demonstrated that an assembly-defective
Gag mutant truncated proximal to the nucleocapsid (NC)
domain (GagDNCDp6; Figure 3A) is not coimmunoprecipi-
tated by aABCE1 under steady-state conditions (5,8,9,15).
Furthermore, a mutational analysis demonstrated that
Figure 2: Intracellular complexes containing radiolabeled Gag and ABCE1 appear shortly after translation and disappear upon
intracellular processing of radiolabeled p55Gag. A) COS-1 cells expressing HIV-1 were pulsed for 15 min with
35S-methionine/cysteine
and chased with unlabeled media. At chase times indicated above panels, cells were harvested and lysates were subjected to
immunoprecipitation under native conditions with aABCE1. Dot indicates position of coimmunoprecipitated p55Gag. B) Collections of
medium at chase times indicated were subjected to immunoprecipitation with aGag. Medium collections in the first 24 h were cumulative,
starting with the beginning of the chase period, while medium collected at later times shows p24Gag release during intervals (24–48 h and
48–72 h). Marker lanes (M Gag, M ABCE) show the positions of p55Gag and ABCE1. All lanes are from the same autoradiograph, with
lanes spliced from elsewhere on the same autoradiograph indicated by dividing line. C) The amount of radiolabeled p55Gag
coimmunoprecipitated with aABCE1 in A was quantitated as percentage of maximum (squares, left-hand y-axis) and was plotted against
theamountof radiolabeled Gag (p24Gagand p25Gag)presentin mediumin B as percentage of maximumradiolabeled p24Gagandp25Gag
accumulated at 72-h chase (circles, right-hand y-axis). Inset shows data with chase time plotted on a logarithmic scale in order to highlight
early time-points. D) Data shown in C are plotted against increase in processed Gag bands (p24Gag and p25Gag) from cell lysates
(triangles, right-handy-axis)andagainsttheamountofradiolabeledGag(p24Gagandp25Gag)presentin mediumas inC (circles,right-hand
y-axis). Graph shows data with chase time plotted on a logarithmic scale in order to highlight early time-points (up to 9.25-h chase).
Accumulation of processed p24Gag and p25Gag bands in lysate (triangles, right-hand y-axis) was quantitated as percentage p24Gag and
p25Gag present at maximum intracellular levels (9.25 h). Processed Gag bands in the media were quantitated as percentage of maximum
radiolabeled p24Gag and p25Gag accumulated at 72-h chase (circles, right-hand y-axis). C,D) When identical time-points were available in
two experiments (filled squares, circles or triangles), data were averaged, with error bars showing SEM. Open squares, circles and
triangles show time-points that were only examined in one of the two experiments. All data are representative of four independent
experiments.
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association (7). To confirm that an assembly-defective Gag
mutant fails to bind ABCE1 in a kinetic assay, as is the case
in a steady-state context, COS-1 cells expressing HIV or
HIV-encoding GagDNCDp6 (HIVDNCDp6, HIV-1 provirus
with a deletion in env and a truncation in Gag proximal to
NC) and mock-transfected cells were pulsed for 1 h and
subjected to immunoprecipitation under denaturing con-
ditions with aGag (Figure 3B) or to immunoprecipitation
under native conditions with aABCE1 (Figure 3C) at 1
versus 24 h into the chase period. Immunoprecipitations
with aGag demonstrated expression of p55Gag and
GagDNCDp6 in cells expressing HIV and HIVDNCDp6,
respectively (Figure 3B). Preparations of virus-like particles
(VLPs) demonstrated that cells expressing HIVDNCDp6
failed to release virus into the medium, unlike HIV-express-
ing cells as expected (Figure S2). In cells expressing HIV,
p55Gag was associated with ABCE1 at 1 h but not at 24 h
(Figure 3C, compare lanes 3 and 4), consistent with pre-
vious pulse-chase results (see Figure 2A). In contrast,
GagDNCDp6 was not associated with ABCE1 at either 1
or 24 h (Figure 3C, at gray arrowhead, lanes 5 and 6),
despite excellent expression (Figure 3B, lanes 6 and 7). In
fact, the aABCE1 coimmunoprecipitation of HIVDNCDp6
looked identical to aABCE1 coimmunoprecipitations from
cells transfected with mock plasmid (Figure 3C, compare
lanes 5 and 6 to lanes 1 and 2). Thus, pulse labeling demon-
strated, as expected, that an assembly-incompetent Gag
mutant truncated proximal to NC failed to associate with
ABCE1 at a chase time when significant amounts of
radiolabeled wild-type Gag were associated with ABCE1.
Because loss of the Gag–ABCE1 association was closely
correlated with p55Gag processing (Figure 2D), we also
examined the effect of protease inactivation on the Gag–
ABCE1 association. In parallel with transfections described
above, COS-1 cells were transfected with equivalent
amounts of HIVPro , a proviral construct encoding point
mutations that inactivate the HIV-1 protease and cause the
release of immature virus rather than mature virus [(16),
J.E. Dooher and J.R. Lingappa, unpublished data]. Surpris-
ingly, p55Gag produced by HIVPro  was associated with
ABCE1 at both 1 and 24 h (Figure 3C, lanes 7 and 8). Thus,
the two HIV-1 mutants we examined have opposite pheno-
types, with assembly-defective Gag from HIVDNCDp6
failing to form complexes with ABCE1, and p55Gag from
the assembly-competent but processing-defective HIVPro 
displaying prolonged association with ABCE1.
To confirm the prolonged Gag–ABCE1 association in cells
expressing HIVPro , we examined a detailed time-course
for HIVPro  versus wild-type HIV from cells that were
Figure 3: Wild-type HIV-1 Gag associates
with ABCE1 transiently, while Gag from
HIVDNCDp6 fails to associate with
ABCE1, and Gag from HIVPro2 shows
prolonged association with ABCE1. A)
Schematic of HIV constructs used. Gag en-
codes matrix (MA), capsid (CA), nucleocapsid
(NC) and p6, while GagPol also encodes the
HIV enzymes protease (Pro), reverse tran-
scriptase (RT) and integrase (IN). Asterisks
indicate sites of point mutations in HIVPro 
construct. B,C) COS-1 cells transfected with
the indicated constructs were pulsed for 1 h
with
35S-methionine/cysteine and chased
with unlabeled media. Lysates were har-
vested at 1 or 24 h into the chase period (as
indicated) and were immunoprecipitated with
aGag after denaturation (B) or with aABCE1
under native conditions (C). Markers for
GagPol, p55Gag and Gag cleavage products
(MA/CA Gag, p24Gag) are shown (M Gag),
and positions of ABCE1, p55Gag and
GagDNCDp6 are indicated by black, white
and gray arrows, respectively in (C). Dots
show the position of coimmunoprecipitated
p55Gag in lanes 3, 7 and 8. All lanes in a given
panel are from thesame autoradiograph, with
dividing lines indicating where lanes from
other regions of the same autoradiograph
are spliced. Data are representative of three
independent experiments.
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medium. Immunoprecipitations of denatured cell lysate
with aGag demonstrated that Gag from HIVPro  failed to
be proteolytically cleaved at any time-point (data not
shown). When cells expressing wild-type HIV were im-
munoprecipitated with aABCE1 under native conditions,
complexes containing Gag and ABCE1 could be detected
for   2.5 h (Figure 4A). However, in cells expressing
HIVPro , high levels of Gag were associated with ABCE1
for at least 28 h, with reduced association at 52 h, and no
detectable association at 77 h (Figure 4A). Notably, the
GagPol polyprotein was also coimmunoprecipitated by
aABCE1, best seen in the coimmunoprecipitations from
cells expressing HIVPro  in Figure 4A. Quantitation re-
vealed that the ratio of radiolabeled Gag to GagPol in the
aABCE1 immunoprecipitations of HIVPro  cell lysates
was as high as 18:1, with an average from multiple time-
points of 10:1, which approximates the Gag to GagPol ratio
found in virions (17,18).
To determine whether the prolonged association was
simply due to higher intracellular levels of Gag produced
by the HIVPro  versus wild-type construct, we trans-
fected parallel plates with different amounts of the HIV
Figure 4: Time-coursedemonstratespro-
longed ABCE1 association with Gag
from HIVPro2 and reduced rate of
HIVPro2 particle release. A) COS-1 cells
expressing 3.0 mg HIV or HIVPro  were
radiolabeled for 15 min with
35S-methio-
nine/cysteine and chased with unlabeled
media. At indicated times, cells were har-
vested and subjected to immunoprecipita-
tion under native conditions with aABCE1.
Markers (M) for the position of Gag and
ABCE1 are shown. Dot shows the position
of coimmunoprecipitated p55Gag in chase
lanes. B) COS-1 cells transfected with
indicated amounts of HIV or HIVPro  plas-
mid (mg) were pulsed for 15 min with
35S-
methionine/cysteine and chased for 15 min
or 10 h with unlabeled media.Lysateswere
subjected to native immunoprecipitation
with aABCE1. Dot shows the position of
coimmunoprecipitated p55Gag in chase
lanes. Data are representative of three
independent experiments. C) VLPs from
cells transfected with 1.5 mg wild-type
HIV (filled squares) or HIVPro  (open
squares) plasmid were prepared using
sucrose cushions, and amount of radio-
labeled Gag was quantitated and graphed
as a percentage of total wild-type virus
release. Total wild-type virus release was
defined as the amount of wild-type virus
accumulated in the medium at 72 h into the
chase. Data are averaged from two inde-
pendent experiments, and error bars indi-
cate SEM. Native immunoprecipitations
were performed on cell lysates in C (data
notshown)andweresimilarto 1.5 mg lanes
shown in B.
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immunoprecipitation with aABCE1 to examine the associ-
ation of p55Gag with ABCE1 at 15 min and 10 h into the
chase period (Figure 4B). Within the range of plasmid
concentrations used, p55Gag from cells expressing wild-
type HIV associated with ABCE1 to similar extents at 15
min but was not associated with ABCE1 at 10 h. In
contrast, p55Gag expressed from the HIVPro  construct
was associated with ABCE1 both at 15 min and at 10 h,
even when the amount of the HIVPro  plasmid was
reduced to 25% of wild-type plasmid (Figure 4B, compare
0.75 mg HIVPro  to 3.0 mg HIV plasmid). These data
indicate that in the absence of p55Gag processing, the
half-life of Gag–ABCE1 complexes becomes significantly
greater than  2 h, unlike when p55Gag is produced from
the wild-type HIV construct, and that this effect appears to
be independent of p55Gag expression levels. This finding
supports the notion that the loss of Gag–ABCE1 com-
plexes at the onset of maturation in cells expressing wild-
type HIV-1 likely represents dissociation of ABCE1 from
p55Gag rather than degradation of Gag–ABCE1 complexes
because mutational inactivation of the HIV-1 protease is
unlikely to inhibit cellular degradation processes but could
conceivably prolong the interaction of p55Gag with cellular
proteins.
Others have demonstrated that protease-defective con-
structs result in reduced virus release (10). To determine
whether the construct exhibiting delayed Gag–ABCE1
dissociation also exhibits reduced virion release, we trans-
fected cells with 1.5 mg wild-type HIV or HIVPro  plasmid,
and collected virus particles by sedimenting medium
through sucrose cushions at varying times following
a 15-min pulse. Aliquots of radiolabeled virion pellets were
analyzed directly by SDS-PAGE rather than by aGag
immunoprecipitation because p55Gag and p24Gag are
immunoprecipitated with different efficiencies by ap24
antibodies and therefore such immunoprecipitations can-
not be directly compared. Quantitation revealed that at 5
and 10 h post-transfection, virion release from cells
expressing HIVPro  was  50% of that released from
cells expressing wild-type HIV, but by 72 h the total
amount of release between the two groups was fairly
similar (Figure 4C). Notably, ABCE1 was not present in
immature virions released by HIVPro  constructs (Figure
S2), as is the case for wild-type mature HIV-1 particles as
well as for immature VLPs produced by expression of
simian immunodeficiency virus Gag alone (5). The lack of
ABCE1 in released virus is consistent with intracellular
dissociation of ABCE1 (Figure 2D). Thus, although pro-
tease activity appears to promote efficient dissociation of
ABCE1 from p55Gag through a direct or indirect mech-
anism, it is not required for ABCE1 dissociation from
p55Gag. Nevertheless, the finding that inactivation of
p55Gag processing correlates with a prolonged half-life
of intracellular Gag–ABCE1 complexes and with reduced
virion release suggests that dissociation of ABCE1 from
Gag is linked to either maturation or virus release.
Intracellular Gag–ABCE1 complexes undergo
a progressive increase in S value
The finding that ABCE1 dissociates from p55Gag at the
onset of maturation suggests that ABCE1 is associated
with p55Gag throughout the capsid assembly process. To
confirm this, we examined whether pulse-labeled Gag–
ABCE1 complexes undergo the increase in size over time
that would be expected upon multimerization of p55Gag
during assembly. Through pulse-chase analysis in a cell-
free HIV-1 capsid assembly system, we had previously
demonstrated that HIV-1 p55Gag associates with ABCE1
and progresses through discrete assembly intermediates
with sedimentation values of  80/150S and then  500S,
culminating in production of the completed  750S imma-
ture capsid upon dissociation of Gag from ABCE1 (8,9). We
had also found that the  80/150S intermediate is highly
transient in the presence of Mg
2þ, but accumulates when
ATP is depleted in the presence of Mg
2þ (5). Consistent
with the ATP dependence of the  80/150S intermediate,
another approach that can be used to trap this complex is
to omit Mg
2þ from harvest and gradient buffers or to add
the chelating agent EDTA (Figure S3). For this reason,
studies presented here were performed in the absence of
Mg
2þ. HIV-expressing COS-1 cells were radiolabeled for
15 min and harvested at various chase times for analysis
on velocity sedimentation gradients followed by immuno-
precipitation of gradient fractions with aABCE1 under
native conditions (Figure 5). At the 15-min chase point,
most of the radiolabeled p55Gag associated with ABCE1
was present in complexes that migrated in the  80/150S
region of the gradient. At 30 min, complexes containing
p55Gag and ABCE1 were present to nearly equivalent
extents in the  80/150S and  500S regions of the
gradient. At 2 h, there were substantially fewer Gag–
ABCE1 complexes in the  80/150S region, and the
majority of complexes containing p55Gag and ABCE1
were in the form of the  500S complex. At this 2-h chase
time, the total amount of radiolabeled Gag complexed with
ABCE1 had decreased, consistent with significant release
of radiolabeled Gag into the medium (see Figure 1A,
Medium, and Figure 2B). At 6 h, when much of the
radiolabeled Gag had been released into the medium as
p24Gag (see Figure 1A, Medium, and Figure 2B), both the
 80/150S and  500S complexes were present in reduced
amounts (Figure 5).
It should be noted that radiolabeled amino acids continue
to be incorporated into newly synthesized p55Gag until at
least 30 min into the chase period (as seen in Figure 1A,
Cells). This continued incorporation of radiolabeled amino
acids likely reflects the time it takes to deplete pools of
radiolabeled aminoacyl transfer RNAs after the labeling
medium is removed. Thus, while radiolabeled p55Gag
polypeptides that completed synthesis during the first 15
min of the chase shifted from the  80/150S complex into
the  500S complex during the 15- to 30-min chase period,
they were replaced by radiolabeled p55Gag polypeptides
that were synthesized after the 15-min chase point and
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chase period. This explains why the total amount of
radiolabeled  80/150S complexes remained relatively
constant until after  30 min into the chase, when pro-
duction of newly radiolabeled p55Gag polypeptides ceased
(Figure 5B). This also explains why the overall number of
Gag–ABCE1 complexes increased until the 30-min chase
point. At the 2- and 6-h chase points, when radiolabeled
p55Gag was no longer being synthesized, progression
of radiolabeled p55Gag from the  80/150S complex to
the  500S complex lead to a decrease in the amount of
the  80/150S complex, while release of p24Gag into the
medium correlated with the progressive decrease in total
intracellular Gag–ABCE1 complexes.
Taken together, the pulse-chase and velocity sedimenta-
tion analyses strongly support a model in which p55Gag
progresses sequentially through intracellular assembly
intermediates of increasing size while associated with
ABCE1. Upon formation of completed capsids of >500S,
ABCE1 dissociates from p55Gag, and p55Gag processing
by the HIV-1 protease begins, leading to intracellular capsid
maturation followed by budding and release from the cell.
Notably, progression of p55Gag over time from  80/150S
to  500S complexes in cells closely corresponds to pulse-
chase data from the cell-free HIV-1 capsid assembly
system that was originally used to identify HIV-1 capsid
assembly intermediates and to define this assembly
pathway (8,9).
Immunogold labeling reveals complexes containing
Gag and ABCE1 at the plasma membrane
The pulse-chase studies described above demonstrated
that ABCE1 associates with assembling p55Gag from
the time of p55Gag synthesis, throughout assembly, to
the time of capsid maturation and virion release. During
this time, the sedimentation value of Gag–ABCE1 com-
plexes increased to approximately that of an immature
capsid, most likely because of Gag multimerization. Be-
cause the late stages of Gag multimerization are known to
occur at membrane sites of assembly, these findings
raised the possibility that complexes containing Gag and
ABCE1 are located at the plasma membrane. While Gag
has been shown to colocalize with endogenous ABCE1 in
immunofluorescence studies (9), neither the exact location
of Gag–ABCE1 complexes nor the morphologic appear-
ance of capsid assembly intermediates has been de-
scribed. To address these questions, we examined these
complexes ultrastructurally in COS-1 cells expressing HIV.
As expected, standard thin-section transmission EM with
negative staining revealed the presence of numerous
electron-dense structures at the plasma membrane
(Figure 6A), which areconsistent with assemblingand bud-
ding HIV-1 capsids observed numerous times by others
[reviewed by Wills and Craven (19)]. We next used single
immunogold labeling to determine the location of Gag and
ABCE1 in cells. For these studies, less fixative and LR
White embedding were used to preserve antigenicity
necessary for immunogold labeling. Because these con-
ditions result in loss of morphologic detail (20), resolution
of fine-structure and electron-dense capsids was reduced.
Nevertheless, sites of capsid assembly and budding were
still easily recognizable (Figure 6B). Immunogold labeling
for Gag alone revealed high-density labeling at sites of
assembling and budding capsids at the plasma membrane
(Figure 6B), as well as lower density labeling in the
cytoplasm of cells expressing HIV. No aGag labeling was
seen in mock-transfected cells (J.E. Dooher and J.R.
Lingappa, unpublished data).
Immunogold labeling of endogenous ABCE1 in mock-
transfected cells revealed labeling throughout the cyto-
plasm, with minimal labeling at the plasma membrane
(Figure 6C). Some ABCE1 labeling was seen in nuclei,
especially within nucleoli, consistent with data from other
groups indicating that ABCE1 is involved in ribosome
export (13,14). Immunogold labeling with either of the
gold-conjugated secondary antibodies in the absence of
the corresponding primary antibody revealed no labeling
(J.E. Dooher and J.R. Lingappa, unpublished data), con-
firming that all labeling was due to aGag and aABCE1.
Figure 5: Intracellular complexes containing Gag and ABCE1
increase to approximately the size of capsids over time. COS-
1 cells expressing HIV-1 were subjected to pulse radiolabeling for
15 min followed by chase with unlabeled medium. At indicated
times, cells were harvested and subjected to velocity sedimenta-
tion, fractionation and immunoprecipitation under native condi-
tionswith aABCE1. A) p55Gag associatedwith ABCE1 in fractions
representing  10S  80/150S and  500S complexes was quan-
titated and shown as assembly profiles. Positions of  10S  80/
150S and  500S complexes are indicated. B) Amount of p55Gag
associated with ABCE1 in fractions representing  80/150S and
 500S complexes at indicated time-points was quantitated and
graphed. All data are from one experiment and are representative
of four independent experiments.
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assembly at the plasma membrane
Upon double labeling of Gag (labeled with 6 nm gold) and
ABCE1 (labeled with 15 nm gold), low-power electron
micrographs of cells expressing HIV revealed high levels of
ABCE1 labeling at sites along the plasma membrane
(Figure 7A). High-power views of regions with ABCE1
labeling at the plasma membrane indicated colocalization
of Gag and ABCE1 at structures representing typical
assembling and budding HIV-1 capsids (Figure 7B–E).
Colocalization occurred at partially assembled, crescent-
shaped capsids that only minimally deformed the plasma
membrane (asterisks in Figure 7C,D), as well as at spher-
ical capsids that were nearly completely surrounded by
plasma membrane (asterisks in Figure 7B,E).
To confirm that ABCE1 specifically colocalizes with
assembling Gag, we compared colocalization of ABCE1
with that of wild-type Gag versus the GagDNCDp6
mutant, which fails to assemble or associate with ABCE1
(8,9,15) (Figure 3). In cells expressing HIVDNCDp6, Gag
labeling occurred primarily at the plasma membrane,
although, as expected, formation of capsid-like structures
was not seen. ABCE1 labeling was diffusely cytoplasmic,
with little ABCE1 labeling seen in proximity to Gag
labeling at the plasma membrane (Figure 8A,B). This
was in complete contrast to the prominent colocalization
seen in cells expressing HIV (Figure 7). To assess
whether there was a significant difference between these
two patterns of colocalization, we quantified the amount
of ABCE1 colocalized with wild-type Gag to the amount
colocalized with the assembly-defective GagDNCDp6
mutant. Colocalization was defined as the presence of
ABCE1 labeling within 100 nm of a cluster of Gag labeling,
with individual clusters of Gag labeling being at least 100
nm apart (for examples, see Figure 9A). In cells express-
ing wild-type HIV, ABCE1 was colocalized with   45% of
wild-type Gag clusters present at the plasma membrane
(Figure 9B). In contrast, ABCE1 was colocalized with only
 15% of GagDNCDp6 clusters located at the plasma
membrane.
To further confirm ABCE1 recruitment into sites of assem-
bly, we performed a separate experiment examining
immunogold labeling of ABCE1 and Gag in COS-1 cells
expressing either HIVPro  or mock plasmid. Cells
expressing HIVPro  were chosen for this comparison to
see whether they also revealed recruitment of ABCE1, as
was the case for cells expressing wild-type HIV in the
previous comparison (Figure 9B). Mock cells were chosen
as a control to determine whether the difference in ABCE1
localization was seen when the control lacks Gag expres-
sion. Using mock-transfected controls prevented us from
directing our analysis to regions of the plasma membrane
containing Gag, so instead we examined the density of
ABCE1 at virus-producing versus control plasma mem-
brane. From electron micrographs representing six cells
expressing HIVPro , we determined the number of
ABCE1 labeling events in 21,568 nm of randomly selected,
virus-producing plasma membrane, and compared this to
the number of ABCE1 labeling events in 26,678 nm of
randomly selected plasma membrane from five mock-
transfected cells. In cells expressing HIVPro ,w e
observed one ABCE1 labeling event per 502 nm of virus-
producing plasma membrane, while in the mock cells, we
observed one ABCE1 labeling event per 3335 nm of
plasma membrane. This indicated that the density of
ABCE1 labeling was  6.6-fold greater at discrete sites
of virus production in cells expressing HIVPro  than at
control plasma membranes from mock-transfected cells.
Thus, quantitation of ABCE1 labeling in cells expressing
either wild-type HIV or HIVPro  indicated that sites of
HIV-1 capsid assembly at the plasma membrane contain
complexes composed of Gag and ABCE1, and demon-
strated specific recruitment of ABCE1 into discrete sites of
assembly at the plasma membrane.
Figure 6: Standard EM and single immunogold labeling of
Gag and ABCE1. COS-1 cells transfected with HIV (A,B) or mock
plasmid (C) were processed for negative staining transmission EM
(A) or for single immunogold labeling with aGag (B; 6-nm gold) or
aABCE1 (C; 15-nm gold). In C, all ABCE1 labeling is indicated with
arrows. Scale bars correspond to 100 nm. Plasma membrane
(PM), cytoplasm (Cyt), nucleus (N) and nucleolus (n) are indicated.
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Here we used a kinetic analysis to demonstrate that
ABCE1, a cellular ATPase, forms intracellular complexes
with HIV Gag upon completion of p55Gag synthesis, and
appears to dissociate from p55Gag just before capsid
maturation and virion release (Figures 2 and 3). Dissoci-
ation ofABCE1 fromp55Gag appearstobe linked top55Gag
polyprotein processing because mutational inactivation of
the HIV-1 protease led to prolonged Gag–ABCE1 associ-
ation (Figure 4). We also found that during the first 2 h after
p55Gagsynthesis,Gag–ABCE1complexesundergoalarge
increase in size that is consistent with immature capsid
assembly (Figure 5). Finally, we used an ultrastructural
approach (immunogold double labeling; Figures 6–9) to
demonstrate that Gag–ABCE1 complexes are present at
sites of capsid formation at the plasma membrane. Thus,
structures that are the hallmark of HIV-1 assembly in cells
Figure 7: Immunogold labeling of ABCE1 with wild-type Gag reveals colocalization. COS-1 cells expressing HIV were processed for
immunogold double labeling with aGag (6-nm gold; indicated by white arrowheads) and aABCE1 (15-nm gold; indicated by black arrows).
A) Low-power view showing plasma membrane (PM), cytoplasm (Cyt), nucleus (N) and nucleoli (n). B) Magnification of boxed area from A.
C–E show high-power views from other fields. Asterisks in B and E show colocalization of Gag and ABCE1 in nearly completed capsids;
asterisks in C and D show colocalization of Gag and ABCE1 in partially assembled capsids. Scale bars correspond to 200 nm.
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[e.g. Gelderblom et al. (23), Mergener et al. (24), Schatzl
et al. (25)] appear to be assembly intermediates contain-
ing p55Gag and at least one cellular factor involved in the
assembly process. Together, our biochemical and ultra-
structural studies suggest that a population of p55Gag is
associated with ABCE1 from the time of p55Gag synthe-
sis, throughout the capsid assembly process, until the
onset of capsid maturation, and that this population of
Gag is localized to plasma membrane sites of assembly.
Moreover, our studies suggest that dissociation of
ABCE1 from Gag during capsid assembly is linked to
virion maturation or to release by as yet undetermined
mechanisms.
Intracellular complexes containing Gag have been reported
by many other groups besides ours (26–34). It is likely that
many different subsets of Gag complexes exist within
a cell, but that only a limited number of these are likely to
be intermediates in capsid assembly, with the rest being
involved in other late events, or being destined for degra-
dation. Evidence for substantial Gag degradation comes
from the finding that when Gag is expressed alone without
the rest of the provirus,  80% of newly synthesized Gag
polypeptides are degraded within 2 h after synthesis (33).
In the pulse-chase studies of COS-1 cells expressing
genomic HIV or HIVPro  constructs reported here, we
also observed that  80% of newly synthesized Gag
Figure 9: Quantitation of Gag–ABCE1 colocalization at the
plasma membrane. Sections of COS-1 cells expressing HIV or
HIVDNCDp6 were analyzed for colocalization of Gag and ABCE1.
Colocalization was defined as ABCE1 labeling within 100 nm of
clusters of Gag labeling at the plasma membrane. A) Examples of
negative (white arrow) and positive (black arrow) colocalization
of Gag and ABCE1 are shown. Scale bar corresponds to 100 nm.
B) Percentage of Gag clusters that were colocalized with ABCE1
was determined for cells expressing HIV versus HIVDNCDp6.
Error bars show SEM from three experiments. A total of 64
micrographsof wild-type Gag and 44 micrographs of GagDNCDp6,
each containing multiple Gag clusters, were counted.
Figure 8: Immunogold labeling of ABCE1 and Gag DNCDp6
demonstrates that they do not colocalize. COS-1 cells express-
ing HIVDNCDp6 were processed for immunogold double labeling
with aGag (6-nm gold; indicated by white arrowheads) and
aABCE1 (15-nm gold; indicated by black arrows). A) Low-power
view showing plasma membrane (PM) and cytoplasm (Cyt).
B) Inset of boxed area in A. Scale bars correspond to 200 nm.
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J.R. Lingappa, unpublished data), consistent with exten-
sive intracellular Gag degradation. Given such evidence for
extensive Gag degradation, we cannot rule out the possi-
bility that intracellular Gag–ABCE1 complexes undergo
degradation. Thus, the loss of Gag–ABCE1 complexes
during the first 2 h of the chase period in Figure 2D could
be due either to dissociation of ABCE1 from Gag at the
onset of capsid maturation and virion release or to degra-
dation of Gag–ABCE1 complexes occurring at the same
time as processing and release of a different population of
Gag polypeptides. However, the very close correlation
between the disappearance of Gag–ABCE1 complexes
and the onset of intracellular Gag processing in Figure 2D
argues in favor of ABCE1 dissociation upon capsid matu-
ration. In addition, results obtained with the mutant con-
taining an inactivated HIV-1 protease (Figure 4) also
support the notion that ABCE1 dissociates from p55Gag
upon capsid maturation and release. Specifically, when the
HIV-1 protease was inactivated, the half-life of Gag–
ABCE1 complexes was greatly prolonged (Figure 4), while
>80% of total Gag produced in these cells underwent
rapid degradation (J.E. Dooher and J.R. Lingappa, unpub-
lished data). It is unlikely that mutational inactivation of Gag
polyprotein processing by the HIV-1 would cause a reduc-
tion in proteasomal degradation of selected Gag-containing
complexes. In light of findings fromthe cell-free system for
HIV-1 capsid assembly documenting that dissociation of
ABCE1 occurs upon completion of the immature HIV-1
capsid with total Gag levels remaining constant (9), a more
likely explanation is that dissociation of ABCE1 occurs less
efficiently when maturation is inhibited and/or virion
release is delayed.
Other findings also argue that Gag–ABCE1 complexes
constitute the pool of Gag destined for assembly and
release rather than a pool of Gag destined for degradation.
First, in this study, we demonstrated that during the first 2
h postsynthesis when the vast majority of Gag polypep-
tides are subject to degradation [(33), J.E. Dooher and J.R.
Lingappa, unpublished data], Gag–ABCE1 complexes
increase in size, achieving the size of completed immature
capsids of >500S, which are much larger than  20S
proteasomal complexes involved in degradation. Secondly,
the finding that Gag–ABCE1 complexes contain p55Gag
and GagPol in a ratio of  1:10 to 1:20 ratio (Figure 4A),
which is characteristic of virions (17,18), also lends
support to the notion that these complexes represent
nascent virions. Thirdly, we have shown that assembly-
incompetent Gag mutants, which likely undergo even
greater amounts of degradation than wild-type Gag, fail
to form any ABCE1-containing complexes (Figure 3) [also
see Lingappa et al. (7), Zimmerman et al. (9), Dooher et al.
(35)]. Finally, there are numerous reports of ABCE1 being
involved in protein synthesis in many eukaryotic species
as described below, but to date, there are no reports
of ABCE1 being involved in protein degradation in any
species.
The observations that Gag–ABCE1 complexes are at the
plasma membrane and that ABCE1 appears to dissociate
from Gag upon capsid maturation are consistent with
previous depletion–reconstitution and dominant-negative
studies showing that ABCE1 is important for assembly of
Gag and virion production (9). Unfortunately, the post-
translational role of ABCE1 in assembly of Gag is not
amenable to study using small interfering RNA knockdown
of ABCE1 because knockdown of this essential protein
leads to rapid loss of translation and cell death as reported
by others (11) and in our hands (J.E. Dooher and J.R.
Lingappa, unpublished data), necessitating the use of
alternate approaches to further document the role of
ABCE1 in HIV assembly. It should also be noted that in
this kinetic study, we do not address how much intracel-
lular Gag is present in the form of Gag–ABCE1 complexes.
This is because all the p24Gag antibodies we have
examined to date immunoprecipitate p55Gag polypeptides
very inefficiently even under denaturing conditions,
thereby preventing us from accurately quantifying Gag–
ABCE1 complexes as a percentage of total radiolabeled
p55Gag in cells.
Although the exact function of ABCE1 during assembly
remains to be determined, the finding that ABCE1 asso-
ciates transiently with p55Gag during assembly and dis-
sociates at the start of virus maturation is consistent with
a chaperone-like mechanism of action for ABCE1. ABCE1
is the sole member of the E family in the ATP-binding
cassette superfamily and is highly conserved in eukaryotes
and archaea (36). In normal cells, it functions during
nucleocytoplasmic transport of ribsosomes and assembly
of preinitiation complexes during translation (11–14,21,22).
ABCE1 from an archaea was recently crystallized and
shown to be capable of undergoing a clamp-like power
stroke (37), but the role of this power stroke in transport
and assembly of ribosomes or the assembly of primate
lentiviral capsids remains to be determined. Notably, these
intracellular ABCE1- and Gag-containing assembly inter-
mediates do not correspond to ribosomes or polysomes
becausethey form  80,  150 and 500S complexes even
in the presence of EDTA (8,9) (Figure S3), which causes
ribosomes to disassemble into their 40 and 60S subunits
[e.g. Ramirez et al. (38), Shor et al.(39)]. While the domains
in ABCE1 that are important for the Gag–ABCE1 associa-
tion have not been mapped yet, it is known that basic
residues in the NC domain of p55Gag act directly or
indirectly to promote Gag–ABCE1 association (7).
Another question that is answered by these studies
concerns the location of ABCE1-containing assembly
intermediates. Immunogold labeling studies indicate that
the partially assembled electron-dense structures that
have been recognized as the hallmark of HIV-1 assembly
in cells in fact constitute the ABCE1-containing assembly
intermediates that have been isolated biochemically from
cells. In the past, such assembling Gag structures at the
plasma membrane have sometimes been referred to as
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this is a misnomer, given the specific recruitment into
these sites of a cellular ATPase ABCE1 that promotes
assembly. Here, quantitation of immunogold labeling ex-
periments revealed a specific recruitment of ABCE1 into
sites of Gag assembly in cells expressing either wild-type
HIV-1 or HIVPro  compared with cells expressing an
assembly-defective HIV-1 Gag protein or mock-transfected
cells. It should also be noted that some ABCE1 proteins
that are colocalized with wild-type Gag clusters at the
membrane are likely to have been missed in our micro-
graphs because they were outside the plane of these  80-
nm thin sections, and because steric hindrance caused by
antibodies and gold particles renders labeling of proteins
inefficient (41). Interestingly, in virus particles that ap-
peared to have completed assembly, ABCE1 frequently
remained in the cytoplasm at the base of the budding virus
stalk (seen in numerous particles in Figure 7), consistent
with the findings that ABCE1 is not packaged into virions
(5) (Figure S2) but rather associates transiently with Gag
during assembly, appears to dissociate at the time of
maturation (Figure 2) and is left behind in the cell when
virions are released. Our finding that ABCE1-containing
 80/150S assembly intermediates form within minutes
after translation (Figures 2 and 5) raises the possibility that
 80/150S intermediates may be present in the cytoplasm.
Cytosolic complexes containing Gag are difficult to identify
in our immunogold labeling studies because the small gold
particles that are easily seen at the plasma membrane are
harder to identify amidst high concentrations of protein
that raise the background in the cytoplasm. Thus, bio-
chemical approaches will be required to determine
whether ABCE1-containing intermediates are present in
the cytoplasm, in addition to the intermediates identified
here at the plasma membrane using ultrastructural
approaches.
These immunogold EM labeling studies also present the
first detailed view of the subcellular localization of primate
ABCE1. Previously, immunofluorescence studies revealed
that ABCE1 is present in the cytosol and the nucleus in
yeast (12–14). It has also been reported to be present in
mitochondria (42). Here we confirm the presence of
ABCE1inthecytoplasm,nucleusandnucleolusbyimmuno-
gold EM labeling, as expected. However, we also demon-
strate that ABCE1, which lacks transmembrane domains
or motifs for fatty acylation, is recruited into discrete sites
at the plasma membrane upon expression of assembly-
competent HIV-1 Gag. Additional studies will be required
to examine whether specific plasma membrane localiza-
tion occurs in normal cells and to determine the mecha-
nism underlying recruitment of ABCE1 to the plasma
membrane.
Finally, pulse-chase studies presented here also demon-
strated that processing of p55Gag by the HIV protease
occurs intracellularly and precedes virion release. This had
previously been shown in infected CEM cells (10), but here
we find similar results using a different HIV-1 protease
mutant in transfected COS-1 cells. This previous study had
also demonstrated that protease inactivation reduces virus
release (10). Here we confirmed that mutational inactiva-
tion of the HIV-1 protease led to delayed virion release, and
extended these observations by demonstrating that pro-
tease inactivation also correlated with prolonged associa-
tion of p55Gag with ABCE1. Whether delayed dissociation
of ABCE1 is a cause or consequence of delayed virus
release and how mutational inactivation of the protease
leads to delayed dissociation will need to be examined in
future studies. Interestingly, we found that immature virus
is eventually released from cells expressing HIVPro  and
that these released immature virions did not contain
ABCE1 (Figure S2). This suggests that dissociation of
ABCE1 from p55Gag eventually does occur despite the
absence of HIV-1 protease activity, albeit at a much later
time. Our finding that protease inactivation correlated both
with a prolonged half-life of intracellular Gag–ABCE1 com-
plexes and with reduced virion release raises the possibil-
ity that events of capsid assembly, maturation, and virus
release are interdependent. Thus, these kinetic studies of
intracellular Gag–ABCE1 complexes also demonstrate that
assembly is followed in an ordered sequence first by the
onset of processing and then by release, and suggest
a mechanistic link between maturation and viral–host
interactions that occur during assembly.
Materials and Methods
Plasmids and cell culture
The plasmid for expression of wild-type HIV-1 (HIV) encodes the full-length
HIV-1 Bru (LAI) genome with a deletion in the env gene and was obtained
from Michael Emerman (43). HIVDNCDp6 and HIVPro  are identical to the
wild-type proviral construct except for the following point mutations that
were engineered by site-directed mutagenesis: a double stop codon was
inserted after aa 363 of Gag to generate HIVDNCDp6, and the protease-
inactivating substitutions D25K, G49W and I50W (16) were engineered into
the protease gene to generate HIVPro . All mutations were verified by
sequencing. Mock plasmid was pcDNA3.1 (Invitrogen, Carlsbad, CA, USA).
COS-1 (ATCC, Manassas, VA, USA) cells were maintained per supplier’s
instructions and were transfected in 60-mm dishes using 24 mL Lipofect-
amine (Invitrogen) and 0.75–3.0 mg plasmid, per manufacturer’s protocol.
H9 cells stably expressing the HIV genome were described previously (5).
Radiolabeling and cell harvests
At  36–40 h post-transfection, cells were radiolabeled by incubation in
starvation medium (serum-free DME lacking methionine and cysteine) for
30 min, pulsed with 1.5 mL starvation medium containing 250 mCi
35S-radiolabeled methionine/cysteine (ICN Pharmaceuticals, Costa Mesa,
CA, USA), rinsed with PBS and chased with 2 mL complete DME containing
0.2 mM cysteine and 0.2 mM methionine and 10% FBS. At harvest, medium
was collected, and cells were rinsed in PBS. For longer chases, medium
was collected at 24 and 48 h into the chase, cells were rinsed with PBS and
complete DME was replaced. For harvest under denaturing conditions,
cells were scraped in 200 mL5 0m M Tris, 1.0% SDS in the presence of
1:100 protease inhibitor cocktail (Sigma-Aldrich, St Louis, MO, USA), boiled
for 5 min and clarified in a microfuge. For preparation of COS-1 cell lysates
under native conditions, cells were harvested on ice in 200–300 mL chilled
native nonionic buffer (0.625% NP40, 10 mM TrisAc, 50 mM KAc, 100 mM
NaCl, pH 7.4) or using the same buffer in the presence of 10 mM EDTA or
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(incubated for 30 min at 378C), when noted. Unlabeled H9 cells expressing
HIV were harvested in 250 mL chilled native nonionic buffer (0.625% NP40,
10 mM TrisAc, 50 mM KAc, 100 mM NaCl, 4 mM MgAc, pH 7.4) alone or
using the same buffer in the presence of 1 mM EDTA or 0.5 U apyrase per
microliter. Native harvests were performed in the presence of a protease
inhibitor cocktail (Sigma-Aldrich), sheared by 30 passes through the rubber
sheath of a 20-gauge angiocath and clarified by centrifugation at 300   g for
8 min at 48C in a GH-3.8 rotor (Allegra 6R centrifuge, Beckman Coulter,
Fullerton, CA, USA) and at 18 000   g for 45 second in a microfuge.
Medium was clarified by centrifugation at 365   g for 10 min at 48C in a GH-
3.8 rotor and passed through a0.22-mm syringe filter. For markersand serial
immunoprecipitations, cells were steady-state radiolabeled by a 30-min
starve, 1-h pulse and 15-min chase. Virus-like particle production was
determined by collecting medium from cells, filtering through a 0.22-mm
syringe filter, underlayering medium with 1.0 mL of 30% w/v sucrose in
water and centrifuging at 162 500   g for 45 min at 48C in an MLS50 rotor
(Beckman Coulter). Preparations of VLP were adjusted to identical vol-
umes, and viral envelopes were disrupted by addition of SDS to a final
concentration of 1.0%.
Immunoprecipitation and Western blotting
For markers and all aGag immunoprecipitations, native lysate was dena-
tured with SDS to 1.0%, or for medium to 0.75%, boiled for 5 min and
diluted to <0.1% SDS with native harvest buffer (lysate) or 50 mM Tris, 2%
BSA, pH 7.4 (media). Immunoprecipitations contained 12.5 mL protein G-
agarose beads (Pierce, Rockford, IL, USA) and 2 mL aGag [aHIV-1 p24
monoclonal antibody (mAb) 24-4, AIDS Reference and Reagent Program, D
Michael Malim (44,45)]. aABCE1 immunoprecipitations were performed by
incubating native lysate with 35–50 mL protein A-TrisAcryl beads (Pierce)
coupled to affinity-purified rabbit aABCE1 (9) or nonimmune rabbit IgG.
Affinity purification and coupling of ABCE1 antiserum was performed
according to the standard protocols (46). Immunoprecipitations in a final
volume of  500 mL were rotated for 2–4 h at 48C, washed twice with 0.1 M
TrisAc, pH 8.0, 1.0% NP40, 50 mM KAc, 100 mM NaCl and twice with
identical buffer lacking NP40. Reactions were eluted in 30–50 mL SDS-
PAGE loading buffer, subjected to SDS-PAGE and visualized by autoradio-
graph or Western blot. For serial immunoprecipitations, parallel aABCE1
immunoprecipitations were eluted by boiling in 200 mL5 0m M Tris, pH 7.4,
and 1.0% SDS. Eluates were pooled, divided equally, diluted to <0.1% SDS
with 50 mM Tris, 2% BSA, pH 7.4, and subjected to repeat immunoprecip-
itation with aABCE1 or aGag as described above, or mouse nonimmune
antibody [5 mL 5 mg/mL mouse IgG (Sigma-Aldrich) with protein G-agarose
or 3 mL aactin (Sigma-Aldrich) with protein A-TrisAcryl].
Western blotting for Gag was performed using primary antibodies ap24Gag
(Dako, Carpinteria, CA, USA) or 183-H12-5C (NIH AIDS Reference and
Reagent Program, Dr Bruce Chesebro and Kathy Wehrly (47–49)) followed
by amouse IgG1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) as
described previously (5).
Gradient analysis
Native cell lysates (200 mL) from pulse-labeled cells were layered onto 2 mL
sucrose-step gradients containing 500 mL each of 20, 40, 50 and 75%
sucrose w/v in 0.625% NP40, 10 mM TrisAc, pH 7.4, 50 mM KAc and 100
mM NaCl. Gradients were centrifuged at 134 000   g for 45 min at 48Ci n
a TLS55 rotor (Beckman Coulter) using a Beckman Coulter Optima
ultracentrifuge. Fractions (300 mL) were collected serially from the top,
subjected to native immunoprecipitation with aABCE1 and analyzed by
SDS-PAGE and autoradiography in parallel with Gag and ABCE1 markers.
p55Gag band intensity in autoradiographs was determined for each
fraction, and values were plotted as relative autoradiography units. Native
cell lysates (200 mL) from unlabeled H9 cells were layered onto 2 mL
sucrose-step gradients containing 400 mL each of 5, 10, 15 and 30%
sucrose w/v in 0.625% NP40, 10 mM TrisAc, pH 7.4, 50 mM KAc, 100 mM
NaCl and 4 mM MgAc with or without 10 mM EDTA. Fractions (200 mL) were
collected serially from the top and analyzed by SDS-PAGE and Western
blotting for Gag. Calibration of gradients with markers for approximate S
values has been described previously (8).
Analysis of Western blots and autoradiographs
Autoradiographs and Western blots were digitized using a Duoscan T1200
(Agfa-Gevaert, Ridgefield Park, NJ) or Canoscan 8400F scanner (Canon,
Lake Success, NY, USA) and PHOTOSHOP 7.0 software (Adobe, San Jose, CA,
USA). Mean p55Gag and p24Gag band intensities in autoradiographs were
determined by quantitating pixels in band aligning with Gag marker and
adjusting for band size and background. Ratio of Gag to GagPol was
determined by band quantitation as described above, followed by a correc-
tion for the number of methionines and cysteines in each band. Quantita-
tion of wild-type HIV versus HIVPro  VLP release was performed as
follows: mature wild-type HIV particles were determined by quantitating
p55Gag and p24Gag bands, while immature HIVPro  particles (which do
not contain any p24Gag) were quantitated using p55Gag. In both cases,
p55Gag signal was corrected by multiplying by 0.54 to normalize p55Gag
signals to the number of radiolabeled residues present in p24Gag.
Immunogold labeling
At  24 h post-transfection, cells were rinsed with PBS and fixed as
indicated below on ice at 48C for  2–5 h. For standard EM, cells were
fixed in half-strength Karnovsky’s fixative (2% paraformaldehyde, 2.5%
glutaraldehyde in 0.1 M cacodylate buffer). For immunogold EM, cells were
fixed in 3% paraformaldehyde and 0.025% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.4. Following fixation, cells were scraped, pelleted
and washed three times in 0.1 M cacodylate buffer. All cell pellets were
dehydrated by successive 15-min treatments of increasing concentrations
of ethanol (50, 70, 95, 100%). For standard EM samples, samples were
treated repeatedly with propylene oxide and then were infiltrated overnight
in 1:2 propylene oxide/Epon resin, and blocks were cured for 48 h at 608C.
Immunogold samples were infiltrated overnight with LR White embedding
resin (London Resin Company Ltd, Reading, Berkshire, England, UK) in
ethanol, changed to straight LR White, embedded in gelatin capsules
(Electron Microscopy Sciences, Hatfield, PA, USA) and cured overnight in
a UV light cryochamber at 48C. Samples were sectioned ( 70 nm), grids
treated with 0.05 M glycine for 20 min at room temperature, rinsed in PBS
and blocked with bovine serum albumin-C (Electron Microscopy Sciences)
in PBS/Tween-20. Primary antibodies aGag [mAb aHIV-1 p24 (Dako)] and
aABCE1 that was dialyzed (Slidalyzer, Pierce) and concentrated (Amicon
concentrator, Millipore, Billerica, MA, USA) were used with goat amouse
IgG conjugated to 6-nm gold and goat arabbit IgG conjugated to 15-nm gold
(Electron Microscopy Sciences) respectively. For double immunolabeling,
grids were incubated with aGag for 1 h at room temperature, then aABCE1
for 1 h, followed by secondary antibodies, fixation with 2% glutaraldehyde
in PBS for 10 min at room temperature, with BSA/PBS/Tween-20 rinses
between all steps and final rinse in distilled water. Samples were
poststained with uranyl acetate for 1 min and lead citrate for 30 seconds.
Similar immunolabeling was obtained using secondary antibodies conju-
gated to 6- and 15-nm gold particles, for Gag and ABCE1 labeling,
respectively. All samples were visualized with a JEOL 1010 or JEOL
1230 microscope (JEOL, Peabody, MA, USA). Cell pellet processing,
immunolabeling and EM were performed by the Fred Hutchinson EM Core
Facility (Seattle, WA, USA). Negatives of photomicrographs were scanned,
and for preparation of figures, the digital images were adjusted in Adobe
Photoshop (Adobe) using the curves function applied uniformly to the entire
image in order to best visualize electron-dense gold particles.
Quantitation of immunolabeling
In comparing cells expressing wild-type HIV with cells expressing
HIVDNCDp6, an experienced microscopist provided printed nondigital
photomicrographs of random fields depicting wild-type Gag and
GagDNCDp6 labeling near the plasma membrane. Colocalization was
determined by counting ABCE1 labeling within 100 nm of Gag clusters in
these photomicrographs, the approximate diameter of immature HIV-1
capsids. A cluster of Gag was defined as a group of two or more Gag
labeling events within 100 nm of the plasma membrane. To avoid counting
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between clusters. Percentage of colocalization was defined as the number
of Gag clusters with ABCE1 within 100 nm of Gag, as a percentage of total
clusters. Error bars represent standard error of the mean (SEM) from three
separate experiments, with a total number of 172 and 372 wild-type Gag
and GagDNCDp6 clusters, counted from 64 and 44 fields, respectively.
In comparing cells expressing HIVPro  with mock-transfected cells, an
experienced microscopist randomly selected 6 HIVPro  cells that exhibited
virus production and then photographed randomly selected areas of plasma
membrane in these cells that contained budding virus particles, producing
24 digital micrographs. Randomly selectedareasof plasma membrane from
five randomly selected mock-transfected cells were also photographed to
produce 17 digital micrographs. In the HIVPro  cells, only areas of
membrane with visible budding virus particles were analyzed (including
a 100-nm margin on either side of the budding virus cluster), while in mock
cells, all plasma membrane regions seen in the micrographs were scored.
ABCE1 labeling was scored as positive only when it was within 100 nm of
plasma membrane that was analyzed. For both groups, the length of
membrane on each digital micrograph was determined using a curve
perimeter tool in Canvas X (Victoria, BC, Canada) and the amount of ABCE1
labeling in the selected region was determined.
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Supplementary Materials
Figure S1: HIV Gag is associated with ABCE1 independently of
ribosomes or polysomes. COS-1 cells expressing HIV (lanes 3–5) or
mock plasmid (lanes 6–8) were pulse radiolabeled with
35S-methionine/
cysteine and chased with unlabeled media. Lysates were harvested under
native conditions using (A) buffer lacking EDTA (lanes 3 and 6), (B) buffer
containing 10 mM EDTA (lanes 4 and 7) or (C) buffer containing RNAse A but
no EDTA (lanes 5 and 8), and were immunoprecipitated with aABCE1.
Markers (M) for the position of Gag and ABCE1 are shown. Dot indicates
position of coimmunoprecipitated p55Gag found in lanes 3–5. Molecular
weight markers are shown to the right.
Figure S2: ABCE1 is not present in substantial quantities in virions
released from cells expressing HIVPro2. A) COS-1 cells were trans-
fected to express HIV, HIVPro ,H I V DNCDp6 or mock plasmid, as shown
by Western blotting (WB) aliquots of cell lysate with aGag. B) Cell lysates
were subjected to immunoprecipitation with aABCE1 under native con-
ditions followed by Western blotting with either aABCE1 (lanes 5–8, top
panel) or aGag (lanes 5–8, bottom panel) to show the relative ratio of
ABCE1 and Gag present in intracellular complexes. VLPs were collected by
sedimenting medium from these cells through a sucrose cushion. ABCE1
was not detected in VLP preparations (lanes 9–12), which contained
amounts of Gag equal to or greater than those found in the immunopre-
cipitated intracellular complexes. Immunoprecipitation of VLP aliquots with
aABCE1 also failed to reveal ABCE1 in VLPs (data not shown). All lanes in
panel B were analyzed in parallel, with the dividing line indicating splicing of
lanes from a single film. Molecular weight markers are shown to the left in
all panels. HC indicates IgG heavy chain detected in immunoprecipitations.
Figure S3: Chelation of divalent cations mimics effect of ATP deple-
tion in enhancing Gag present in  80/150S complexes. Human H9 cells
stably expressing the HIV-1 provirus were harvested in nondetergent buffer
containing Mg
2þ,M g
2þ and apyrase (which depletes ATP), or EDTA, and
analyzed by velocity sedimentation and Western blotting for Gag. Positions
of  10S and  80/150S complexes are indicated. Data are representative of
more than four experiments.
Supplemental materials are available as part of the online article at http://
www.blackwell-synergy.com
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